COMPANIES COVERED
RainDanceTechnologiesDownload FREE Report Sample
Download Free sampleLung Cancer Liquid Biopsy Market contains market size and forecasts of Lung Cancer Liquid Biopsy in Global, including the following market information:
Global Lung Cancer Liquid Biopsy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Lung Cancer Liquid Biopsy market was valued at 438 million in 2021 and is projected to reach US$ 1056.2 million by 2028, at a CAGR of 13.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Exosomes and RNA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lung Cancer Liquid Biopsy include RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Sysmex Inostics and Cynvenio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lung Cancer Liquid Biopsy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Liquid Biopsy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Lung Cancer Liquid Biopsy Market Segment Percentages, by Type, 2021 (%)
Exosomes and RNA
CTCs and ctDNA
Global Lung Cancer Liquid Biopsy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Lung Cancer Liquid Biopsy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Lung Cancer Liquid Biopsy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Lung Cancer Liquid Biopsy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lung Cancer Liquid Biopsy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Lung Cancer Liquid Biopsy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
